Jonathan MacQuitty, PhD | Personalis Chairman
Pat Balthrop | Recently retired CEO of Luminex, Inc.
Previously, Pat was CEO, President and Director of Luminex Corporation, a publicly-traded diagnostics, tools and devices company. During his ten year tenure as CEO, Luminex increased sales more than eight-fold, transitioned from a loss position to segment-leading levels of profitability, made several strategic acquisitions and introduced numerous new products.
Prior to Luminex, Balthrop was President of Fisher Healthcare from 2002 to 2004. He also had a 20 year career at Abbott from 1981 to 2002, where he ran the company’s worldwide commercial operation, was the first head of Abbott Vascular, ran several R&D programs and was GM of the Far East Area, among other accomplishments.
In addition to his board position at Personalis, Balthrop is a director of Oxford Immunotec Global, a high growth diagnostics company focused on the development and commercialization of proprietary diagnostic tests for the management of immune-related conditions. Balthrop is also a director of NextGxDx, a private healthcare informatics company that is harnessing the power of the clinical value of the human genome.
Balthrop has an MBA from the Kellogg School of management at Northwestern University, and a BS in Biology from Spring Hill College.
Ken Ludlum | Chairman, Personalis Audit Committee and Chief Financial Officer of CareDx, Inc.
Prior to 25 years in operating positions, he spent 10 years as an investment banker, primarily with Montgomery Securities. He holds a Bachelor of Science degree from Lehigh University and an MBA from Columbia Business School.
Vincent Miles | Partner, Abingworth
Previously, Vincent was at Millennium Pharmaceuticals where he held VP positions in business development, strategic planning and corporate communications. Earlier, he was Director of the technology transfer office at the Dana-Farber Cancer Institute and held VP positions in business development and R&D at RiboGene and Pharmacia. He began his career in R&D at Amersham International. He has a BSc in Biochemistry and a PhD in Molecular Biology from University College London.
Chris Schaepe | Founder, Lightspeed Venture Partners
John West | Chief Executive Officer
From 2009 through mid-2011, Mr. West served as CEO of ViaCyte, Inc, a company leveraging stem cell technology to develop a diabetes cell therapy.
In late 2009, Mr. West’s family became the first healthy family of four have their genomes sequenced. Their experience working with the Stanford team on genome interpretation led to the foundation of Personalis.
Mr. West received BS and MS engineering degrees from MIT, and earned an MBA from the University of Pennsylvania’s Wharton School of Business.